C12Q2565/501

DETECTION OF GENOMIC SEQUENCES USING COMBINATIONS OF PROBES, PROBE MOLECULES AND ARRAYS COMPRISING THE PROBES FOR THE SPECIFIC DETECTION OF ORGANISMS

Methods of identifying homologous genomic sequences that may be present in a sample utilizing combinations of probes binding differently to genomic sequences from different organisms, arrays for distinguishing homologous genomic sequences, systems for distinguishing homologous genomic sequences, and bacteria binding probe molecules useful in the methods, arrays, and systems.

DETECTION OF GENOMIC SEQUENCES USING COMBINATIONS OF PROBES, PROBE MOLECULES AND ARRAYS COMPRISING THE PROBES FOR THE SPECIFIC DETECTION OF ORGANISMS

Methods of identifying homologous genomic sequences that may be present in a sample utilizing combinations of probes binding differently to genomic sequences from different organisms, arrays for distinguishing homologous genomic sequences, systems for distinguishing homologous genomic sequences, and bacteria binding probe molecules useful in the methods, arrays, and systems.

Universal tags with non-natural nucleobases

The present invention relates to amplification primers with a universal tag and sequencing primers comprising at least one non-natural nucleobase capable of hybridizing to a complementary non-natural nucleobase. The present invention further relates to amplification methods of nucleic acid amplification and sequencing using an amplification primer with a universal tag and sequencing primers, as well as kits and solid supports comprising such primers and tags.

Universal tags with non-natural nucleobases

The present invention relates to amplification primers with a universal tag and sequencing primers comprising at least one non-natural nucleobase capable of hybridizing to a complementary non-natural nucleobase. The present invention further relates to amplification methods of nucleic acid amplification and sequencing using an amplification primer with a universal tag and sequencing primers, as well as kits and solid supports comprising such primers and tags.

Methods and Apparatus for Nanoparticle-assisted Nucleic Acid Amplification, Hybridization and Microarray Analysis
20170275680 · 2017-09-28 ·

Nucleic acid hybridization methods are disclosed. An example method comprises: immobilizing probe nucleic acid molecules on a surface; flowing target nucleic acid molecules to the immobilized probe nucleic acid molecules on said surface in a hybridization buffer solution; washing said surface with a wash solution which comprises nanoparticles; and detecting the presence of duplexes on said surface comprising a strand of one of said target nucleic acid molecules and a strand of one of said probe nucleic acid molecules. In some embodiments, the target nucleic acid molecules are generated using a helicase-dependent amplification method wherein the reaction solution comprises nanoparticles.

Methods and Apparatus for Nanoparticle-assisted Nucleic Acid Amplification, Hybridization and Microarray Analysis
20170275680 · 2017-09-28 ·

Nucleic acid hybridization methods are disclosed. An example method comprises: immobilizing probe nucleic acid molecules on a surface; flowing target nucleic acid molecules to the immobilized probe nucleic acid molecules on said surface in a hybridization buffer solution; washing said surface with a wash solution which comprises nanoparticles; and detecting the presence of duplexes on said surface comprising a strand of one of said target nucleic acid molecules and a strand of one of said probe nucleic acid molecules. In some embodiments, the target nucleic acid molecules are generated using a helicase-dependent amplification method wherein the reaction solution comprises nanoparticles.

METHODS AND MATERIALS FOR MULTIPLEXED COLLECTIONS OF FUNCTIONAL LIGANDS

This invention relates to methods and materials for multiplexed utilization of collections of functional ligands, particularly to methods and materials for selecting for and/or utilizing particular desirable traits of functional ligands in a multiplexed manner, and more particularly to methods and materials for selecting for and/or utilizing particular structural changes of functional ligands in a multiplexed manner.

METHODS AND MATERIALS FOR MULTIPLEXED COLLECTIONS OF FUNCTIONAL LIGANDS

This invention relates to methods and materials for multiplexed utilization of collections of functional ligands, particularly to methods and materials for selecting for and/or utilizing particular desirable traits of functional ligands in a multiplexed manner, and more particularly to methods and materials for selecting for and/or utilizing particular structural changes of functional ligands in a multiplexed manner.

INHIBITOR OF NON-SPECIFIC BINDING OF NUCLEIC ACID, HYBRIDIZATION REAGENT AND NUCLEIC ACID HYBRIDIZATION METHOD
20210395802 · 2021-12-23 ·

A non-specific-binding inhibitor enables, in detection of a target nucleic acid by hybridization, effective inhibition of cross-hybridization between the target nucleic acid and complementary strands of sequences similar thereto, which non-specific-binding inhibitor has a stable quality among production lots, and a hybridization method for nucleic acid uses the inhibitor. The non-specific-binding inhibitor for nucleic acid includes a nucleic acid which has a base length of 2 to 11 bases and in which the content of a guanine base(s) and/or methylated guanine base(s) in the entire base sequence is not less than 70%.

INHIBITOR OF NON-SPECIFIC BINDING OF NUCLEIC ACID, HYBRIDIZATION REAGENT AND NUCLEIC ACID HYBRIDIZATION METHOD
20210395802 · 2021-12-23 ·

A non-specific-binding inhibitor enables, in detection of a target nucleic acid by hybridization, effective inhibition of cross-hybridization between the target nucleic acid and complementary strands of sequences similar thereto, which non-specific-binding inhibitor has a stable quality among production lots, and a hybridization method for nucleic acid uses the inhibitor. The non-specific-binding inhibitor for nucleic acid includes a nucleic acid which has a base length of 2 to 11 bases and in which the content of a guanine base(s) and/or methylated guanine base(s) in the entire base sequence is not less than 70%.